SUBSCRIBE
SUBSCRIBE
News   FDA

AMAG Pharmaceuticals, Inc. Gets FDA Request for More Data on Anemia Drug

October 20, 2008 | 
1 min read
CAMBRIDGE, Mass. - Biotechnology company AMAG Pharmaceuticals Inc. said Monday the Food and Drug Administration wants more information on a prospective anemia drug before considering it for approval.
FDA Approvals Regulatory
Food and Drug Administration (FDA)
MORE ON THIS TOPIC
IN PARTNERSHIP WITH Pii, A JABIL COMPANY
Webinar: Bridging Formulation & Device | Integrated Supply Chain Strategies for US Pharma Manufacturing
September 17, 2025
 · 
1 min read
 · 
BioSpace Insights
Businessman tied up with red tape. concept of struggle, limitation and trap or challenge
FDA
FDA’s Ad Crackdown Targets Novo, Lilly’s Oprah Special on GLP-1s
September 17, 2025
 · 
3 min read
 · 
Annalee Armstrong
Podcast
China Crackdown, UK Exit, Novo Layoffs, Adcomm Flip Flop, More
September 17, 2025
 · 
2 min read
 · 
Heather McKenzie
man pulling each of the opposite ends of a rope in black and white, on a blue background with some blank space on top
Obesity
Novo, Lilly Jostle For Market Lead in Obesity With New Regulatory Efforts
September 16, 2025
 · 
2 min read
 · 
Tristan Manalac